Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 8—August 2011

Mixed Genotype Infections with Hepatitis C Virus, Pakistan

Cite This Article

To the Editor: The prevalence of hepatitis C virus (HCV) infection is high (8% of the population) in Pakistan (1). HCV is an RNA virus that has a high mutation rate. This high rate results in extensive genetic heterogeneity, and HCV isolates are found as either quasispecies or genotypes (2). Humans can be co-infected with >1 genotype (mixed genotype infection) of this virus (3). The rate of HCV mixed genotype infections is extremely variable for different regions and for the same group of patients tested by using different assays (4). Thus, it is difficult to determine the prevalence of mixed genotype infections by currently available assays, including direct DNA sequencing, because they are designed to identify only the HCV genotype dominant in that particular population. Consequently, genotypes present at lower frequencies could be missed or mistyped (5).

To determine the prevalence of HCV mixed genotype infections, we retrospectively analyzed genotyping data for paired serum samples from 22,125 HCV-infected patients during the past 11 years (March 2000–May 2010) for all regions in Pakistan by using molecular-based genotype-specific methods (6,7). A total of 12,036 (54.4%) were male patients and 10,089 (45.6%) were female patients.

The sensitivity and reliability of the assay we used has been assessed and found to be superior to restriction fragment length polymorphism analysis and serotyping methods for detection of mixed genotypes in a viral population. Our method can detect a small amount (8.3%) of HCV RNA in a mixed genotype population (7). Restriction fragment polymorphism analysis can detect 2 genotypes only if 1 of them represents >41.6% of the genotypes in a mixed genotype population.

Of 22,125 HCV RNA-positive serum samples, type-specific PCR bands were observed in 18,181 (82.2%) samples and 3,944 (17.8%) were not typeable. A total of 1,007 (5.5%) patients had HCV mixed genotype infections.

Figure A1

Thumbnail of Frequency of mixed genotype infections with hepatitis C virus in 1,007 patients, Pakistan, March 2000–May 2010.

Figure A1. Frequency of mixed genotype infections with hepatitis C virus in 1,007 patients, Pakistan, March 2000–May 2010.

The distribution of mixed genotype infections in 1,007 patients is shown in Figure A1. Infection with mixed genotype 3a + 3b was most prevalent (43.79%). Age distribution of patients with mixed genotype infections is shown in the Table. Approximately 33% of patients with mixed genotype infections were 31–40 years of age and 22.5% were 41–50 years of age.

Patterns of HCV mixed genotype infections in Pakistan are similar to those reported from India and Iran (8). However, the prevalence of HCV mixed genotype infections was lower (2%) (8) for Iran than for Pakistan. This lower rate may have been caused by use of a genotyping kit that can detect only genotypes 1a, 1b, 2, and 3a. Thus, mixed infections with other genotypes would not have been detected. A recent study in Brazil reported that mixed genotype infections were detected in 3.9% of intravenous drug users and 7.1% of former injecting drug users (9). These rates were similar to those in our study. In contrast, data from Sweden and Russia showed no mixed genotype infections in serum samples of chronically infected intravenous drug users, hemodialysis patients, and patients with hemophilia (10).

Women (288/7,390, 3.89%) in Pakistan had significantly fewer HCV mixed genotype infections than men (719/10,791, 6.66%) (p<0.01). This finding might be the result of women having fewer risk factors for contracting mixed genotype infections. Possible risk factors for infection with mixed genotype infections analyzed were blood transfusions and use of blood products (51.3%); multiple use of needles or syringes (18.4%); sharing razors during shaving or circumcision, piercing instruments, nail clippers, and toothbrushes (13.7%); and major or minor dental surgery (9.5%). Mode of transmission was not clear for 7.1% of the patients.

In conclusion, the prevalence of HCV mixed genotype infections in Pakistan is higher than previously reported and higher among men (p<0.01). Comprehensive and detailed investigations are warranted to evaluate the clinical role of chronic HCV mixed genotype infections, provide essential information that can be used to determine type and duration of therapy needed, and predict disease outcome.



We thank the clinicians and patients for participating in the study.

This study was partially supported by Ministry of Science and Technology, Government of Pakistan.


Sadia Butt, Muhammad IdreesComments to Author , Irshad Ur Rehman, Haji Akbar, Muhammad Shahid, Samia Afzal, Saima Younas, and Iram Amin
Author affiliations: Author affiliation: University of the Punjab, Lahore, Pakistan



  1. Idrees  M, Lal  A, Naseem  M, Khalid  M. High prevalence of hepatitis C virus infection in the largest province of Pakistan. J Dig Dis. 2008;9:95103. DOIPubMedGoogle Scholar
  2. Martell  M, Esteban  JI, Quer  J, Genesca  J, Weiner  A, Gomez  J. Hepatitis C virus circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 1992;66:32259.PubMedGoogle Scholar
  3. Jarvis  LM, Ludlam  CA, Simmonds  P. Hepatitis C virus genotypes in multi-transfused individuals. Haemophilia. 1995;1(Suppl):37. DOIGoogle Scholar
  4. Forns  X, Maluenda  MD, Lopez-Labrador  FX, Ampurdanes  S, Olmedo  E, Costa  J, Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol. 1996;34:251621.PubMedGoogle Scholar
  5. Lau  JY, Mizokami  M, Kolberg  JA, Davis  GL, Prescott  LE, Ohno  T, Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis. 1995;171:2819. DOIPubMedGoogle Scholar
  6. Idrees  M. Development of an improved genotyping assay for the detection of hepatitis C virus genotypes and subtypes in Pakistan. J Virol Methods. 2008;150:506. DOIPubMedGoogle Scholar
  7. Idrees  M, Riazuddin  S. Evaluation of three different HCV typing methods for the detection of mixed genotype infections. J Dig Dis. 2011. In press. DOIPubMedGoogle Scholar
  8. Zarkesh-Esfahani  SH, Kardi  MT, Edalati  M. Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study. Virol J. 2010;7:69. DOIPubMedGoogle Scholar
  9. Silva  MB, Andrade  TM, Silva  LK, Rodart  IF, Lopes  GB, Carmo  TM, Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil. Mem Inst Oswaldo Cruz. 2010;105:299303. DOIPubMedGoogle Scholar
  10. Viazov  S, Widell  A, Nordenfelt  E. Mixed infection with two types of hepatitis C virus is probably a rare event. Infection. 2000;28:215. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1708.100950

Related Links


Table of Contents – Volume 17, Number 8—August 2011

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Muhammad Idrees, Division of Molecular Virology and Molecular Diagnostics, National Centre of Excellence in Molecular Biology, University of Punjab, 87 West Canal Bank Rd, Thokar Niaz Baig, Lahore 53700, Pakistan

Send To

10000 character(s) remaining.


Page created: August 15, 2011
Page updated: August 15, 2011
Page reviewed: August 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.